Your microbiome is the key to living without bloating.
A healthy gut microbiome maintains optimal digestion.
Treat the cause of bloating, not the symptoms...
biomiq is a new generation bacterial therapy for bloating, and is...
- Cost-effective (~$1.60/day)
- Easy to purchase (shop online)
- Delivered to your door (within 1 week)
When patients ingested specific Lactobacillus strains;
~ Bloating was no longer present in 89% of patients.*
~ Constipation frequency and severity decreased.*
~ Bloating and abdominal distention severity was relieved.*
~ Digestive system health was maintained and supported.*
~ Healthy digestive system flora was enhanced.*
“I have been using biomiq for around 4 months now, and my bloating has definitely subsided.” ~ Priscilla, 50
“My symptoms have subsided at least 50% - pretty much no bloating and a lot less pain.” ~ Michael, 28
biomiq digestive contains live and active forms of two scientifically-validated strains.
The concentration of our formulation is not just made-up numbers! Too few organisms are likely to be non-efficacious, and too many could make symptoms worse!
Instead, our formulation is made at specific doses that are scientifically supported in peer-reviewed studies.
*Supporting Scientific Literature
Lombardo et al. (2009) Clinical evaluation of Lactobacillus paracasei subsp. paracasei F19 with gluco-oligosaccharides in the short-term treatment of irritable bowel syndrome. Microb Ecol Health D. 21: 28-32
Lahner et al. (2012) High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease. World J Gastroenterol.
Chen et al. (2019) Differential Effects of Lactobacillus casei Strain Shirota on Patients With Constipation Regarding Stool Consistency in China. J Neurogastroenterol.
Kato-Katoaka et al. (2016) Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress. Appl Environ Microbiol.
Ritchie & Romanuk (2012) A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS ONE. 7: e34938.
Ouwehand (2017) A review of dose-responses of probiotics in human studies. Beneficial Microbes. 8 (2): 143-151.
Sandler et al. (2000) Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Dig Dis Sci. 45: 1166–71.